BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 16442855)

  • 1. Alzheimer's disease and endocytic dysfunction: clues from the Down syndrome-related proteins, DSCR1 and ITSN1.
    Keating DJ; Chen C; Pritchard MA
    Ageing Res Rev; 2006 Nov; 5(4):388-401. PubMed ID: 16442855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mice deficient for the chromosome 21 ortholog Itsn1 exhibit vesicle-trafficking abnormalities.
    Yu Y; Chu PY; Bowser DN; Keating DJ; Dubach D; Harper I; Tkalcevic J; Finkelstein DI; Pritchard MA
    Hum Mol Genet; 2008 Nov; 17(21):3281-90. PubMed ID: 18676989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DSCR1/RCAN1 regulates vesicle exocytosis and fusion pore kinetics: implications for Down syndrome and Alzheimer's disease.
    Keating DJ; Dubach D; Zanin MP; Yu Y; Martin K; Zhao YF; Chen C; Porta S; Arbonés ML; Mittaz L; Pritchard MA
    Hum Mol Genet; 2008 Apr; 17(7):1020-30. PubMed ID: 18180251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of Abeta11-40/42 peptide deposition in Alzheimer's disease and young Down's syndrome brains: implication of N-terminally truncated Abeta species in the pathogenesis of Alzheimer's disease.
    Liu K; Solano I; Mann D; Lemere C; Mercken M; Trojanowski JQ; Lee VM
    Acta Neuropathol; 2006 Aug; 112(2):163-74. PubMed ID: 16865398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endosome function and dysfunction in Alzheimer's disease and other neurodegenerative diseases.
    Nixon RA
    Neurobiol Aging; 2005 Mar; 26(3):373-82. PubMed ID: 15639316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Down syndrome, Alzheimer's disease and seizures.
    Menéndez M
    Brain Dev; 2005 Jun; 27(4):246-52. PubMed ID: 15862185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Down syndrome and Alzheimer's disease: a link between development and aging.
    Lott IT; Head E
    Ment Retard Dev Disabil Res Rev; 2001; 7(3):172-8. PubMed ID: 11553933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alzheimer's disease and down syndrome: from meiosis to dementia.
    Petronis A
    Exp Neurol; 1999 Aug; 158(2):403-13. PubMed ID: 10415146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trafficking of Alzheimer's disease-related membrane proteins and its participation in disease pathogenesis.
    Suzuki T; Araki Y; Yamamoto T; Nakaya T
    J Biochem; 2006 Jun; 139(6):949-55. PubMed ID: 16788045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual-specificity tyrosine(Y)-phosphorylation regulated kinase 1A-mediated phosphorylation of amyloid precursor protein: evidence for a functional link between Down syndrome and Alzheimer's disease.
    Ryoo SR; Cho HJ; Lee HW; Jeong HK; Radnaabazar C; Kim YS; Kim MJ; Son MY; Seo H; Chung SH; Song WJ
    J Neurochem; 2008 Mar; 104(5):1333-44. PubMed ID: 18005339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alzheimer's disease pathogenesis: role of aging.
    Harman D
    Ann N Y Acad Sci; 2006 May; 1067():454-60. PubMed ID: 16804026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bidirectional Regulation of Amyloid Precursor Protein-Induced Memory Defects by Nebula/DSCR1: A Protein Upregulated in Alzheimer's Disease and Down Syndrome.
    Shaw JL; Zhang S; Chang KT
    J Neurosci; 2015 Aug; 35(32):11374-83. PubMed ID: 26269644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upregulation of three Drosophila homologs of human chromosome 21 genes alters synaptic function: implications for Down syndrome.
    Chang KT; Min KT
    Proc Natl Acad Sci U S A; 2009 Oct; 106(40):17117-22. PubMed ID: 19805187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cooperation to amplify gene-dosage-imbalance effects.
    de la Luna S; Estivill X
    Trends Mol Med; 2006 Oct; 12(10):451-4. PubMed ID: 16919501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Down syndrome fibroblast model of Alzheimer-related endosome pathology: accelerated endocytosis promotes late endocytic defects.
    Cataldo AM; Mathews PM; Boiteau AB; Hassinger LC; Peterhoff CM; Jiang Y; Mullaney K; Neve RL; Gruenberg J; Nixon RA
    Am J Pathol; 2008 Aug; 173(2):370-84. PubMed ID: 18535180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting the role of the endosome in the pathophysiology of Alzheimer's disease: a strategy for treatment.
    Tate BA; Mathews PM
    Sci Aging Knowledge Environ; 2006 Jun; 2006(10):re2. PubMed ID: 16807486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain site-specific gene expression analysis in Alzheimer's disease patients.
    Yokota T; Mishra M; Akatsu H; Tani Y; Miyauchi T; Yamamoto T; Kosaka K; Nagai Y; Sawada T; Heese K
    Eur J Clin Invest; 2006 Nov; 36(11):820-30. PubMed ID: 17032350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dysfunction of autophagy and endosomal-lysosomal pathways: Roles in pathogenesis of Down syndrome and Alzheimer's Disease.
    Colacurcio DJ; Pensalfini A; Jiang Y; Nixon RA
    Free Radic Biol Med; 2018 Jan; 114():40-51. PubMed ID: 28988799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DSCR1 (ADAPT78) lethality: evidence for a protective effect of trisomy 21 genes?
    Kluetzman KS; Perez AV; Crawford DR
    Biochem Biophys Res Commun; 2005 Nov; 337(2):595-601. PubMed ID: 16198305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroanatomy of Down syndrome in vivo: a model of preclinical Alzheimer's disease.
    Teipel SJ; Hampel H
    Behav Genet; 2006 May; 36(3):405-15. PubMed ID: 16485178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.